ArticleCrohn's & colitis 3602026

Subcutaneous infliximab in inflammatory bowel disease: bridging the gap between theory and practice.

Lucine Vuitton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.